Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-01-500337
Filing Date
2001-03-30
Accepted
2001-03-30 00:00:00
Documents
8
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS INC. FORM 10K w47017e10-k.htm 10-K 292227
2 EX-3.02 AMENDED AND RESTATED BYLAWS w47017ex3-02.txt EX-3.02 37308
3 EX-10.63 EMPLOYMENT LETTER AGREEMENT w47017ex10-63.txt EX-10.63 9315
4 EX-10.64 EMPLOYMENT LETTER AGREEMENT w47017ex10-64.txt EX-10.64 9766
5 EX-13.01 PORTIONS OF COMPANY'S 2000 ANNUAL REPORT w47017ex13-01.txt EX-13.01 159146
6 CONSENT OF KPMG LLP w47017ex23-01.txt EX-23.01 991
7 GRAPHIC w47017pi5-178.gif GRAPHIC 1271
8 GRAPHIC w47017pi5-110.gif GRAPHIC 1223
  Complete submission text file 0000950133-01-500337.txt   513535
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

EIN.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 1587179
SIC: 2834 Pharmaceutical Preparations